Drug
Donafenib tosylate clinical trials
A product of Donafenib; its studies count on that page too.
Keep track of what changes. Save the donafenib tosylate studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2024 (2)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 1
Suzhou Zelgen Biopharmaceuticals Co.,Ltd (5) · Changsha Taihe Hospital (1)
Often tested with
Tested in the same studies.
Bevacizumab (1) · Erfonrilimab (1) · Nilvanstomig (1) · Toripalimab (1)
Studies
Open first, then newest update. How each study uses donafenib tosylate is read from its arms, and is right about nine times in ten.
Testing it · 6
- A Study Evaluating the Efficacy and Safety of ZG005 in Combination With Donafenib or Bevacizumab in Patients With Advanced Hepatocellular CarcinomaNot yet recruitingNot applicableChangsha Taihe HospitalNCT06233994Written as Donafenib Tosilate Tablets
- A Phase 1/2 Study of Donafenib in Combination With KN046 in Advanced Gastrointestinal TumorsTerminatedPhase 1/2Suzhou Zelgen Biopharmaceuticals Co.,LtdNCT04612712Written as Donafenib Tosilate Tablets
- A Study of ZG005 Combined With Donafenib in Patients With Advanced Solid TumorStatus unknownPhase 1/2Suzhou Zelgen Biopharmaceuticals Co.,LtdNCT06239298Written as Donafenib Tosilate Tablets
- A Study of Donafenib Monotherapy in Advanced Oesophageal CancerTerminatedPhase 1/2Suzhou Zelgen Biopharmaceuticals Co.,LtdNCT02489201Written as donafenib tosilate tablets
- Donafenib Monotherapy for Previously Treated Metastatic Gastric CancerTerminatedPhase 1/2Suzhou Zelgen Biopharmaceuticals Co.,LtdNCT02489214Written as donafenib tosilate tablets
- Toripalimab Combined With Donafenib in the Treatment of Advanced Hepatocellular CarcinomaStatus unknownPhase 1/2Suzhou Zelgen Biopharmaceuticals Co.,LtdNCT04503902Written as Donafenib Tosilate Tablets